Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 8 papers. Top paper: “Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolism”.
Samantha S. Soldan, Alessandra De Leo, Zhong Deng, Drew Frase, Emma M. Anderson +7 more
Zhong Deng, Shyam Twayana, Settapong T Kosiyatrakul, Olga Vladimirova, Paul M. Lieberman +2 more
Zhong Deng, Olga Vladimirova, Nitish Gulve, F. Brad Johnson, William C. Drosopoulos +3 more
Alessandra De Leo, Zhong Deng, Andreas Wiedmer, James E. Hayden, Paul M. Lieberman +1 more
Zhong Deng, Samantha S. Soldan, Olga Vladimirova, Jayamanna Wickramasinghe, Hongwu Zheng +3 more
Chenhe Su, Zhong Deng, Samantha S. Soldan, Olga Vladimirova, Jayamanna Wickramasinghe +4 more
Yizhe Wang, Inah Hwang, Ja-Young Jang, Libo Xu, Zhong Deng +14 more
Yizhe Wang, Inah Hwang, Ja-Young Jang, Libo Xu, Zhong Deng +14 more